Knight Therapeutics | GUD - PE Price to Earnings

Stock Price
6.18
Daily Change
0.03 0.49%
Monthly
-4.78%
Yearly
-1.12%
Q1 Forecast
5.95

Knight Therapeutics reported 91.09 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Acasti Pharma 9.94 0.08 Mar/2021
Akebia Therapeutics 26.5 0.19 Sep/2023
Aurora Cannabis 23.27 0 Sep/2025
Cronos Group 21.37 7.75 Sep/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
IQVIA Holdings 26.59 2.03 Dec/2025
Knight Therapeutics 91.09 0.73 Sep/2025
Moderna 27.22 14.51 Jun/2023
Organigram Holdings 235 224.49 Sep/2025
Organon & Co 3.75 0.87 Dec/2025
Revvity 49.87 16.58 Dec/2025
Tectonic Therapeutic 4.01 0.63 Mar/2024
Viatris 10.4 11.84 Sep/2025